Portfolio Update

4 April 2007 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC (the "Company") QUARTERLY STATEMENT OF INVESTMENTS In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii), the Company discloses the following: * Investments valuing greater than 5% of the Company's gross assets comprise the following: Company Name Value of % of Total Investment at Portfolio Assets 31 March 2007 NOVARTIS CHF0.50 REGD 21,052,785 7.29 GENENTECH INC COM STK USD0.02 NPV 20,427,002 7.07 PFIZER INC COM USD0.05 20,456,359 7.08 WYETH COM USD0.333 18,147,133 6.28 JOHNSON & JOHNSON COM USD1 14,926,780 5.17 SCHERING-PLOUGH CORPORATION COM USD0.50 14,841,604 5.14 * The ten largest investments held by the Company comprise the following: Company Name Value of Investment % of Total at Portfolio Assets 31 March 2007 NOVARTIS CHF0.50 REGD 21,052,785 7.29 GENENTECH INC COM STK USD0.02 NPV 20,427,002 7.07 PFIZER INC COM USD0.05 20,456,359 7.08 WYETH COM USD0.333 18,147,133 6.28 JOHNSON & JOHNSON COM USD1 14,926,780 5.17 SCHERING-PLOUGH CORPORATION COM USD0.50 14,841,604 5.14 AMGEN COM USD0.0001 14,028,424 4.86 TAKEDA PHARAMACEUTICAL CO NPV 13,017,604 4.51 CHUGAI PHARMACEUTICAL COMPANY JPY50 12,820,423 4.44 MEDIMMUNE INC COM USD0.01 12,647,057 4.38 - ENDS - For further information please contact: Tracey Lago, Senior Company Secretary Close Investments Limited Telephone: 020 7426 6219
UK 100

Latest directors dealings